Track SIGA and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
SIGA Technologies Inc
31 East 62nd Street, New York, NY, United States, 10065
IPO
1997
Employees
49
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q4 20211-1
0
Analyst Ratings
No coverage data
No analyst ratings data available